Literature DB >> 17067717

Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer.

Niels Reinmuth1, Elisabeth Piegelbrock, Miriam Raedel, Nicole Fehrmann, Heike Hintelmann, Ruth Wagner, Wolfgang E Berdel, Michael Thomas, Lutz Freitag, Rolf M Mesters.   

Abstract

To evaluate characteristics and prognostic impact of different structure types of intratumoural blood vessels, tissue samples of 72 patients with primary stages I and II non-small cell lung cancer (NSCLC) were analysed. Performing immunohistochemistry, 45 of 56 analysed tumours (80%) demonstrated an obvious alveolar vascular pattern with tight coverage with perivascular cells in at least parts of the sample. After an overall median follow-up of 139 months for surviving patients, tumours with an alveolar vascular pattern showed a significantly better overall survival (OS) compared to those with an entirely angiogenic vascular pattern (108 months versus 63 months; p<0.05). Furthermore, high expression of angiopoietin-1 (Ang-1) correlated with OS (p<0.05). In contrast, expression of Ang-2 or vascular endothelial growth factor was not significantly associated with survival. Collectively, alveolar vessel architecture and angiopoietin expression appear to be common phenomenons in early stage NSCLC and may serve as prognostic factors.

Entities:  

Mesh:

Year:  2006        PMID: 17067717     DOI: 10.1016/j.lungcan.2006.09.025

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

Review 1.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

2.  CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.

Authors:  Stuart J Smith; Hanna Tilly; Jennifer H Ward; Donald C Macarthur; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Acta Neuropathol       Date:  2012-02-07       Impact factor: 17.088

3.  Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.

Authors:  Sigve Andersen; Tom Donnem; Khalid Al-Shibli; Samer Al-Saad; Helge Stenvold; Lill-Tove Busund; Roy M Bremnes
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

4.  Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.

Authors:  Zi-Xue Xuan; Su Zhang; Shou-Jun Yuan; Wei Wang; Jia Yu
Journal:  World J Surg Oncol       Date:  2016-09-02       Impact factor: 2.754

5.  [The influence of inhibiting angiopoietin-2 on the biological characteristics of bronchogenic adenocarcinoma].

Authors:  Bailing Li; Guanxin Zhang; Xiaolei Hou; Yang Yuan; Xiaohong Liu; Dejun Gong; Shengdong Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-07

6.  Pancreatic adenocarcinomas with mature blood vessels have better overall survival.

Authors:  Eriko Katsuta; Qianya Qi; Xuan Peng; Steven N Hochwald; Li Yan; Kazuaki Takabe
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

7.  [The Supernatant Obtained from Cultured Anip973 Cells Enhances the Biological Activities of HUVEC].

Authors:  Cuicui Zhang; Yueya Li; Jing Wang; Kai Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.